BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9990068)

  • 1. Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression.
    Qi C; Zhu Y; Pan J; Yeldandi AV; Rao MS; Maeda N; Subbarao V; Pulikuri S; Hashimoto T; Reddy JK
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1585-90. PubMed ID: 9990068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes.
    Le Jossic-Corcos C; Duclos S; Ramirez LC; Zaghini I; Chevillard G; Martin P; Pineau T; Bournot P
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):49-58. PubMed ID: 15238219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.
    Jia Y; Qi C; Kashireddi P; Surapureddi S; Zhu YJ; Rao MS; Le Roith D; Chambon P; Gonzalez FJ; Reddy JK
    J Biol Chem; 2004 Jun; 279(23):24427-34. PubMed ID: 15150259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.
    Post SM; Duez H; Gervois PP; Staels B; Kuipers F; Princen HM
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1840-5. PubMed ID: 11701475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
    Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Princen HM; Kooistra T
    Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism.
    Qi C; Zhu Y; Pan J; Usuda N; Maeda N; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    J Biol Chem; 1999 May; 274(22):15775-80. PubMed ID: 10336479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate.
    Passilly P; Schohn H; Jannin B; Cherkaoui Malki M; Boscoboinik D; Dauça M; Latruffe N
    Biochem Pharmacol; 1999 Sep; 58(6):1001-8. PubMed ID: 10509752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
    Kim MS; Sweeney TR; Shigenaga JK; Chui LG; Moser A; Grunfeld C; Feingold KR
    Metabolism; 2007 Feb; 56(2):267-79. PubMed ID: 17224343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.
    Lee SS; Pineau T; Drago J; Lee EJ; Owens JW; Kroetz DL; Fernandez-Salguero PM; Westphal H; Gonzalez FJ
    Mol Cell Biol; 1995 Jun; 15(6):3012-22. PubMed ID: 7539101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver.
    Sarkar J; Qi C; Guo D; Ahmed MR; Jia Y; Usuda N; Viswakarma N; Rao MS; Reddy JK
    Gene Expr; 2007; 13(4-5):255-69. PubMed ID: 17605299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell.
    Barbera MJ; Schluter A; Pedraza N; Iglesias R; Villarroya F; Giralt M
    J Biol Chem; 2001 Jan; 276(2):1486-93. PubMed ID: 11050084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex.
    Surapureddi S; Viswakarma N; Yu S; Guo D; Rao MS; Reddy JK
    Biochem Biophys Res Commun; 2006 May; 343(2):535-43. PubMed ID: 16554032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
    Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
    J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver.
    Guo D; Sarkar J; Suino-Powell K; Xu Y; Matsumoto K; Jia Y; Yu S; Khare S; Haldar K; Rao MS; Foreman JE; Monga SP; Peters JM; Xu HE; Reddy JK
    J Biol Chem; 2007 Dec; 282(50):36766-76. PubMed ID: 17962186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice.
    Wan YJ; Cai Y; Lungo W; Fu P; Locker J; French S; Sucov HM
    J Biol Chem; 2000 Sep; 275(36):28285-90. PubMed ID: 10866995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.
    Cherkaoui-Malki M; Meyer K; Cao WQ; Latruffe N; Yeldandi AV; Rao MS; Bradfield CA; Reddy JK
    Gene Expr; 2001; 9(6):291-304. PubMed ID: 11764000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.
    Meyer K; Lee JS; Dyck PA; Cao WQ; Rao MS; Thorgeirsson SS; Reddy JK
    Carcinogenesis; 2003 May; 24(5):975-84. PubMed ID: 12771043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.